Cargando…
Incidence of Allergic Drug Eruption due to Cotrimoxazole in HIV-Positive Individuals with CD4 ≤200 Cells/ul
Allergic drug eruptions (ADE) remain a challenge in people living with HIV (PLWH), requiring more studies to guide clinical approaches. While cotrimoxazole is widely used as prophylaxis in PLWH, relationship between client characteristics toward the occurrence of cotrimoxazole ADEs is still poorly u...
Autores principales: | Rosali, Irene, Virgayanti, Putu Siska, Marta, Della Sabrina, Danudirgo, Emon Winardi, Hadinata, Sisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893344/ https://www.ncbi.nlm.nih.gov/pubmed/36700255 http://dx.doi.org/10.1177/23259582221146946 |
Ejemplares similares
-
Mycetoma due to Nocardia Africana/Nova Treated Successfully with Cotrimoxazole and Moxifloxacin
por: Bhandari, Molisha, et al.
Publicado: (2021) -
Successful treatment of cerebral toxoplasmosis with cotrimoxazole
por: Patil, Harsha V., et al.
Publicado: (2011) -
Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014) -
Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014) -
Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021)